JD Health CEO: Will sign contracts with over 20 global pharmaceutical and health brands, including Pfizer, Merck, and Novo.

At the CIIE, JD Health CEO Cao Dong stated that during this year's expo JD Health will sign concentrated agreements with more than 20 global pharmaceutical and health brands, including Pfizer, Merck, Novo, Takeda, Boehringer Ingelheim, Haleon's Sino-American SmithKline, Novartis, and LEO Pharma. Several pharmaceutical companies have worked with JD Health for more than 10 years, and this year's CIIE builds on existing partnerships with expanded cooperation spanning new product launches, new product exclusive distribution, patient management, and AI innovation. JD Health has now established deep partnerships with the global top 50 multinational pharmaceutical companies. It is understood that as of the first three quarters of 2026, JD Health had launched more than 100 new drugs online, exceeding the total for all of last year.